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Type 1 diabetes (T1D) is a common chronic childhood disorder with increasing prevalence in most countries including India [1]. Children with diabetes are known to 
have impaired lipid metabolism due to chronic hyperglycemia [2]. 
Impaired lipid metabolism is further likely to lead to cardiovascular 
complications in children with diabetes which can be a major 
cause of morbidity and mortality [3].
Vitamin D deficiency is common in general population; 
however, reports suggest that its prevalence is higher in children 
and adolescents with diabetes than in general population [4-6]. 
Vitamin D is believed to stimulate insulin receptor expression 
and also insulin-induced glucose transport in vitro; hence, its low 
concentrations are associated with impaired insulin sensitivity [7]. 
It also regulates fatty acid metabolism in skeletal muscle and 
adipose tissue, and previous work suggests that its deficiency 
increases the risk of dyslipidemia [8].
Since Indian children with diabetes are likely to have Vitamin D 
deficiency and are also likely to have deranged lipid profile [3,9], 
we conducted a study on children with diabetes with primary 
objective to study the effect of Vitamin D supplementation on 
lipid profile and secondary as on glycemic control (hemoglobin 
A1c [HbA1c]) in children with T1D.
MATERIALS AND METHODS
This was a prospective, non-blinded, single-arm, supplementation 
study conducted over 15 months at a tertiary level care pediatric 
endocrine unit in Western Maharashtra from January 2015 to June 
2017. The inclusion criterion was children between 3 and 18 years 
of age with T1D who were on treatment, with disease duration 
of more than 1 year. Children with associated disorders such as 
celiac disease, hypothyroidism, and other autoimmune conditions 
were excluded. The institutional ethics committee approved the 
study protocol and parents gave written informed consent and 
children assent (as appropriate) for the study.
Data pertaining to age (date of birth), gender, medical 
history, insulin dosage, date of diagnosis of T1D, and 
anthropometry (height in centimeters, weight in kg, and body 
mass index [kg/meter square]) [10] were noted. Data regarding 
parent’s education and family income were also collected and 
used to assess socioeconomic status of the family using the 
Kuppuswamy’s method [11]. Biochemical tests were performed 
after an overnight fasting (of more than 12 h) between 7 and 10 
AM in the morning; 6 ml of blood was drawn under strict aseptic 
precautions using plain and ethylenediaminetetraacetic acid 
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vacutainers (BD Franklin Lakes, NJ, USA). Serum was separated 
after centrifugation at 2500 rpm for 15 min at room temperature 
within 2 h of collection.
Tests performed included glycosylated hemoglobin (HbA1c by 
high-performance liquid chromatography method), high-density 
lipid cholesterol (HDL-C), total cholesterol (TC), and triglyceride 
(TG) (measured by enzymatic method). Low-density lipoprotein 
cholesterol (LDL-C) and very LDLC concentrations were 
calculated using Friedewald equation. Vitamin D, i.e., 25 (OH) D 
concentrations was estimated by enzyme-linked immunosorbent 
assay (Developmental language disorder Diagnostics 
GmbH, intra-assay coefficients of variation (CV), 4.9; 
interassay CV, 7.8%). Parathyroid hormone (PTH) concentration 
was measured by chemiluminescent immunoassay (Siemens, 
India). Vitamin D levels were classified as sufficient >50 nmol/L, 
insufficient 30–50 nmol/L, and deficient <30 nmol/L [12].
However, extraskeletal benefits of Vitamin D have been 
observed at concentrations of >45 ng/ml (>112 nmol/L) [13]. 
Bone profile included serum calcium, phosphorus, alkaline 
phosphatase (STAR 21, colorimetric method, interassay 
variation <5%), and PTH (ELISA, Bio-Rad-iMark, interassay 
variation <10%). Lipid parameters were classified for 
dyslipidemia [14] (high TC >200 mg/dL, high TGs >100 mg/dL, 
high LDL >130 mg/dL, and low HDL <40 mg/dL).
Sunlight exposure was assessed using structured validated 
questionnaire [15]. Information on sunlight exposure in minutes 
(between 7 AM and 11 AM, 11 AM and 3 PM, and 3 PM and 
7 PM), mode of travel and transport, clothing pattern, use 
of cap or helmet, and sunscreen use was noted [16]. Data on 
physical activity were collected by interview method using the 
QAPACE questionnaire for children that were adapted for Indian 
children [17]. Time spent in sports activities was considered as 
moderate activity [18].
Dietary data were collected using a 24-h recall on 3 non-consecutive 
days of week, through a face-to-face interview using multiple-pass 
method. Nutrient intakes were calculated using C-DIET version 2.0 
(which comprises nutritive values of cooked foods and raw foods 
database of National Institute of Nutrition, India) [19]. Carbohydrate 
density, i.e., the amount of carbohydrate consumed per 1000 kcal 
was calculated using the formula: Carbohydrate density = (Total 
carbohydrate intake/total calorie intake)×1000. Similarly, fat density 
and zinc density were also computed [20].
All children were supplemented with Vitamin D, 1000 IU daily 
as an oral capsule, which was lipid soluble, and in gel form, soft 
capsule, non-chewable, advised to be taken after meal once daily. 
The dose of 1000 IU was decided based on the upper safe limit of 
Vitamin D in children as per the American Association of Pediatric 
Guidelines, 2011 [21]. Children and parents were instructed 
not to chew the capsule. As the previous studies show that 
underprivileged children have poor calcium intake [22], children 
were also supplemented with 500 mg of elemental calcium daily.
Children were called to the center monthly and tablets for the 
next month were dispensed and empty packets were collected. 
A percentage of intake and distributed capsule was calculated. 
Compliance was assessed by regular phone calls, weekly text 
messages, and in person during follow-up at every monthly 
visit. No adverse events such as hypercalciuria (urinary spot 
calcium and creatinine ratio) or signs of Vitamin D toxicity 
related to the supplementation were observed. After 1 year of 
supplementation, these children underwent repeat assessment of 
all above parameters. Percentage change in HbA1c, cholesterol, 
and Vitamin D was computed.
All data were entered into Microsoft Excel (version 2015) 
and were analyzed using IBM SPSS version 25 (Bengaluru, 
India). Normality of data was checked and normal variables were 
described as mean ± standard deviation and non-normal variables 
as median (interquartile range), (non-normal variables included 
PTH, phosphorus, physical activity, and sunlight exposure). 
Paired t-test was used to compare differences in baseline and end 
line parameters among normally distributed parameters. For non-
normally distributed variables, non-parametric tests were used. 
Multiple logistic regression analysis was performed to assess 
improvements in TC and HbA1c. In Model I and II, HbA1c and 
Vitamin D were the independent variables while in Models III 
and IV, physical activity, dietary factors, and sunlight exposure 
were independent variables. Disease duration was included in all 
models. Based on earlier literature [2,7], for 20% reduction in 
mean cholesterol concentrations for achieving 80% power at 5% 
level of significance, the estimated sample size was 130 subjects.
RESULTS
A total of 145 children were enrolled in the study and 136 
completed 1 year supplementation. Baseline characteristics of 
subjects who did not complete the study were similar to the 136 
subjects who completed the study (p>0.1). Mean age at enrollment 
was 12.5±3.9 years (65 boys and 71 girls). The baseline and end 
line anthropometric and lifestyle parameters are presented in 
Table 1. Results were similar in both boys and girls (p>0.1). The 
Table 1: Baseline and end line anthropometry and lifestyle 
parameters
Parameter Total (n=136)
Baseline End line
Age (year) 12.5±3.9 13.5±3.9
Height (cm) 140.8±18.1 144.8±17.7
Height Z score −0.5±1.5 −0.4±1.9
Weight (kg) 36±14.1 39.9±14.1
Weight Z score* −0.5±1.1 −0.3±1
BMI 17.4±3.7 18.8±7.5
BMI Z score −0.3±0.9 −0.2±1.1
Waist Z score* −0.9±2.1 −1.2±1
Disease duration (year) 4.5±3.5 5.5±3.6
Insulin requirement (IU/kg/Day) 1±0.4 1.1±0.3
Boys:Girls 65:71 65:71
Moderate activity (min/week)* 213±252 164.4±240.9
Effective sunlight exposure 
(min/week)
49.6±41.3 49±31.9
(*− p<0.05). BMI: Body mass index
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average compliance of the supplementation was around 90% in 
the children. At baseline 35, 27, 15, 4, and 55 were in pubertal 
stage 1, 2, 3, 4, and 5, respectively. At end line, the pubertal status 
of the study population was 26, 20, 20, 7, and 61 in stage 1, 2, 3, 
4, and 5, respectively. During the study period, 19.28 episodes per 
100 patient-years of diabetic ketoacidosis were observed.
Biochemical parameters showed significant improvement 
in HbA1C (p<0.001) and bone profile including serum alkaline 
phosphatase, Vitamin D [25(OH) D], PTH, and phosphorus 
(p<0.05 for all). However, serum calcium did not change 
significantly. Lipid profile showed lowering of total serum 
cholesterol, HDL, and LDL (p<0.05), whereas TG (p<0.001) and 
cholesterol:HDL (p<0.05) increased. Percentage of children with 
total and LDL cholesterol within reference range was higher at 
end line than at baseline (97.8% vs. 91.1%); although the TG 
concentrations increased, the percentage within reference range 
remained similar (91.9% end line and baseline 89.7%). The 
details are mentioned in Table 2.
At baseline, of 136 children, 57 (41.9%) were Vitamin D 
deficient, 54 (39.7%) were insufficient, and 25 (18.4%) were 
sufficient. At the end line, 17 (12.5%) were deficient, 49 (36%) 
were insufficient, and 70 (51.5%) children were sufficient. The 
mean HbA1c was not different in the groups with deficient, 
insufficient, and sufficient Vitamin D levels at end line. However, 
reduction in cholesterol was significantly higher (23%) in the 
sufficient group versus the insufficient and deficient group (13% 
and 11%, respectively).
In the regression analysis, Model I showed that there was 
a significant improvement in Vitamin D with improvement in 
cholesterol concentrations (p<0.05). Model II showed that HbA1c 
improved along with improvement in cholesterol concentrations 
(p<0.05). Model III showed that carbohydrate density in the diet 
was associated with improvement in cholesterol concentrations 
(p<0.05). Model IV showed that diet and activity did not influence 
HbA1c improvement. The details are mentioned in Table 3.
DISCUSSION
Our results suggest that 1 year daily supplementation with 
1000 IU Vitamin D and 500 mg calcium in underprivileged 
children with T1D resulted in a reduction in waist circumference 
and HbA1c, and improvement in the bone profile. Although mean 
HDL reduced, low HDL concentrations have been reported in 
healthy Indian children (lower than 1 mmol/L) [23].
We found that Vitamin D with calcium supplementation 
in children with T1D resulted in a decrease in TC and LDL 
concentrations. Similar results have been reported in adults 
with type 2 diabetes mellitus in a recent meta-analysis by 
Jafari et al. [24]. Cholecalciferol (Vitamin D3) and 25(OH) D 
inhibit HMG-CoA reductase activity (a rate-limiting enzyme in 
cholesterol synthesis) in human skin fibroblasts and hence lower 
cholesterol concentrations [25]. We also found that carbohydrate 
density in the diet was associated with cholesterol concentrations. 
It is suggested that there is an unfavorable impact on lipid profile 
with increase in carbohydrate intake [26]. Reduction in HDL 
cholesterol after supplementation with Vitamin D has also been 
previously reported [24], which could be attributed to lowering 
of TC.
We found that although the mean TG values at end line 
increased, the percentage of children within the reference range 
for TGs remained the same. Data on TG concentrations in 
Vitamin D supplemented children with T1D are scarce. A study 
was done by Javed et al. in obese adolescents where children 
received 100,000 IU Vitamin D3 orally once a month for 
3 months, a significant increase in TG was noted [27]. In another 
study by Patwardhan et al., one group with low 25 (OH) D 
concentrations was supplemented with 1000 IU Vitamin D daily 
for a period of 6 months while the other group received increased 
sunlight exposure. It was noted that while there was no change in 
TG in the Vitamin D supplemented group, authors found a non-
significant increase in TG concentrations in group that received 
higher sunlight exposure [28].
With Vitamin D and calcium supplementation, we observed 
improvement in the bone profile and modest improvement in 
Vitamin D concentrations. Literature reports suggest that for 
higher increase in Vitamin D, higher doses up to 4000 IU/day 
may have to be used [29]. Marwah et al., 2018, concluded that 
1000 IU/day of Vitamin D might be required to achieve and 
maintain Vitamin D sufficiency in 97% of healthy adolescent 
girls, whereas 2000 IU/day would achieve sufficiency in 100% 
of girls [30]. Similar observations have been documented 
with a requirement of higher doses of 2000 IU daily in at-risk 
group children in the studies done by Sacheck et al. [31] and 
Lewis et al. [32].
We found an improvement in HbA1c concentrations, although 
the glycemic control was still out of the optimal range. The 
reason for poor glycemic control could be because most of the 
children in our clinic belong to underprivileged families and 
poor glycemic control in such families has been reported by 
Secrest et al., 2011 [33]. In a study done by Aljabri et al, 80 patients 
with T1D who had 25(OH) D concentrations <50 nmol/L were 
Table 2: Baseline and end line biochemical parameters (*−p<0.05)
Parameter Total (n=136)
Baseline End line
Alkaline phosphatase (IU/L)* 245.9±96.7 148.7±75.9
HbA1C (%)* 10.3±2.1 9.4±1.7
Vitamin D (nmol/L)* 33.6±18.5 51.1±21.8
PTH (ng/L)* 58.5 (43) 44 (37.5)
Serum calcium (mmol/L) 2.3±0.7 2.4±0.2
Serum phosphorus (mmol/L)* 1.5±0.2 1.2±0.9
Urinary spot calcium 
creatinine ratio (mg/mg)
0.1±0.09 0.13±0.1
Cholesterol (mmol/L)* 4.1±1.1 3.3±0.8
HDL (mmol/L)* 1.3±0.3 1±0.4
LDL (mmol/L)* 2.4±1 1.8±0.8
Triglyceride (mmol/L)* 0.8±0.4 1±0.4
VLDL (mmol/L) 0.4±0.2 0.4±0.2
Cholesterol: HDL* 3.2±0.8 3.5±1
HDL: High-density lipid, LDL: Low-density lipoprotein, PTH: Parathyroid hormone, 
HbA1C: Hemoglobin A1c, VLDL: Very low-density lipoprotein
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supplemented with Vitamin D3 and improvement in glycemic 
control was observed in Vitamin D-replete patients [34]. 
Furthermore, a recent Egyptian study found that 3 months of 
supplementation with Vitamin D resulted in an improvement 
in glycemic control [35]. An Indian study by Sharma et al. 
reported a falling trend in HbA1c on supplementation with 
Vitamin D and calcium, though the difference was not statistically 
significant [36]. We did not find that the HbA1c was influenced 
by dietary intake and physical activity.
Our study has several limitations, an important one being we 
did not have a control group for this study; many of our children 
with diabetes were Vitamin D deficient; thus, having a control 
group without supplementation was not possible. However, at 
our center, we do annual tests on all children with diabetes who 
regularly attend clinics and have monthly follow-ups. In children 
who were not supplemented with vitamin D with disease duration 
was >2 years, mean lipid profile [3.22 mmol/L (baseline)–4.1 
mmol/L (after 1 year)], Vitamin D [40 nmol/L (baseline)–44 
nmol/L (after 1 year)], and HbA1c [9.1% (base;ine) vs. 8.8 % 
(endline)] were not different at two successive annual checks, 
unlike in our study participants who had an improvement in lipid 
profile and glycemic control at end line. Another of our limitation 
was that the study participants’ glycemic control was poor and 
remained so after supplementation. Strategies to improve the lipid 
profile in these children are of utmost importance.
CONCLUSION
Daily supplementation with Vitamin D along with calcium in 
children with T1D resulted in an improvement in lipid profile and 
Table 3: Regression analysis of factors associated with lipid profile improvement
Parameters Biochemical predictors Lifestyle predictors
Model I Model II Model III Model IV
Improvement in 
cholesterol category
Improvement in 
HbA1c category
Improvement in 
cholesterol category
Improvement in 
HbA1c category
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
HbA1C
Cat1
Cat2
Cat3
Cat4
0.6 (0.24–1.4)
0.7 (0.27–1.6)
1.5 (0.6–3.8)
1
Improvement in cholesterol
Cat1
Cat2
Cat3
Cat4
0.43 (0.18–1.06)* (0.06)
0.57 (0.23–1.41)
0.38 (0.16–0.91)*
1
Improvement in Vitamin D
Cat1
Cat2
Cat3
Cat4
0.3 (0.15–0.94)*
0.4 (0.16–0.97)*
0.38 (0.15–0.94)*
1
0.87 (0.36–2.13)
0.97 (0.40–2.36)
2.11 (0.88–5.03)
1
Disease duration 0.44 (0.87–1.1) 0.67 (0.79–1.02) 0.95 (0.86–1.06) 1.03 (0.94–1.1)
Lifestyle
Moderate activity 0.99 (0.99–1) 1.001 (1–1.002)
Sunlight 0.99 (0.98–1) 1.002 (0.99–1.013)
Carbohydrate density
Cat1
Cat2
Cat3
Cat4
6.2 (0.88–44.26)* (0.06)
5.4 (1.03–28.1)*
5.99 (1.55–23.04)**
1
0.31 (0.048–2.02)
0.73 (0.14–3.76)
0.53 (0.13–2.15)
1
Fat density
Cat1
Cat2
Cat3
Cat4
2.03 (0.31–13)
1.09 (0.27–4.38
1.38 (0.4–4.75)
1
0.25 (0.03–1.66)
0.40 (0.10–1.53)
0.27 (0.09–0.83)
1
Zn density
Cat1
Cat2
Cat3
Cat4
1.84 (0.7–4.86)
1.64 (0.61–4.35)
1.31 (0.54–3.2)
1
0.895 (0.36–2.22)
0.479 (0.17–1.28)
0.85 (0.34–2.11)
1
*p<0.05, ** p<0.001 OR: Odds ratio, CI: Confidence interval
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also in glycemic control. It may be a useful strategy for reducing 
their cardiometabolic risk.
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